Cyclerion Therapeutics Inc
NASDAQ:CYCN
Cash Flow Statement
Cash Flow Statement
Cyclerion Therapeutics Inc
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||||
| Net Income |
(108)
|
(112)
|
(115)
|
(153)
|
(130)
|
(128)
|
(123)
|
(106)
|
(93)
|
(85)
|
(78)
|
(71)
|
(68)
|
(60)
|
(52)
|
(51)
|
(48)
|
(48)
|
(44)
|
(38)
|
(29)
|
(11)
|
(5)
|
0
|
3
|
(5)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
8
|
12
|
13
|
20
|
19
|
20
|
20
|
17
|
16
|
15
|
13
|
12
|
10
|
10
|
9
|
8
|
8
|
6
|
5
|
3
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
10
|
11
|
12
|
16
|
17
|
19
|
20
|
18
|
16
|
13
|
11
|
11
|
16
|
17
|
13
|
13
|
5
|
4
|
6
|
5
|
4
|
(10)
|
(11)
|
(12)
|
(12)
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
(1)
|
4
|
2
|
6
|
3
|
(2)
|
(12)
|
(15)
|
(11)
|
(8)
|
0
|
1
|
(0)
|
1
|
3
|
3
|
1
|
(3)
|
(1)
|
(4)
|
(6)
|
(5)
|
(5)
|
(3)
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
|
| Cash from Operating Activities |
(95)
N/A
|
(100)
-5%
|
(98)
+3%
|
(132)
-35%
|
(105)
+21%
|
(103)
+1%
|
(102)
+1%
|
(97)
+5%
|
(89)
+8%
|
(81)
+10%
|
(72)
+10%
|
(58)
+20%
|
(49)
+15%
|
(42)
+15%
|
(37)
+13%
|
(35)
+4%
|
(40)
-15%
|
(42)
-5%
|
(41)
+4%
|
(34)
+16%
|
(30)
+13%
|
(27)
+10%
|
(21)
+21%
|
(17)
+20%
|
(11)
+32%
|
(6)
+46%
|
(4)
+31%
|
(3)
+21%
|
(3)
+18%
|
(1)
+51%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(3)
|
(5)
|
(9)
|
(9)
|
(7)
|
(6)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
-23%
|
(3)
-68%
|
(5)
-53%
|
(9)
-72%
|
(8)
+7%
|
(7)
+20%
|
(6)
+7%
|
(2)
+67%
|
(2)
+27%
|
0
N/A
|
3
+14 100%
|
3
+2%
|
3
N/A
|
1
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
10
N/A
|
10
+0%
|
0
N/A
|
10
N/A
|
0
-100%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
175
|
175
|
176
|
176
|
1
|
25
|
25
|
25
|
55
|
31
|
31
|
31
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
97
|
102
|
101
|
137
|
87
|
61
|
36
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
97
N/A
|
102
+5%
|
101
-1%
|
137
+36%
|
262
+92%
|
236
-10%
|
212
-11%
|
175
-17%
|
4
-98%
|
28
+573%
|
28
+0%
|
28
+0%
|
55
+96%
|
31
-44%
|
31
0%
|
31
0%
|
0
-100%
|
0
-27%
|
0
-73%
|
0
N/A
|
5
N/A
|
5
N/A
|
5
0%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
-9%
|
3
+147%
|
|
| Change in Cash | |||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
149
+1 487 500%
|
125
-16%
|
103
-18%
|
72
-30%
|
(87)
N/A
|
(54)
+38%
|
(44)
+18%
|
(27)
+40%
|
9
N/A
|
(8)
N/A
|
(4)
+48%
|
(4)
+3%
|
(40)
-868%
|
(42)
-5%
|
(41)
+4%
|
(34)
+16%
|
(25)
+27%
|
(11)
+54%
|
(6)
+49%
|
(1)
+75%
|
(1)
+29%
|
(6)
-497%
|
(4)
+30%
|
(2)
+53%
|
(2)
+23%
|
2
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||||
| Free Cash Flow |
(97)
N/A
|
(102)
-5%
|
(101)
+1%
|
(137)
-36%
|
(114)
+17%
|
(112)
+2%
|
(109)
+2%
|
(104)
+5%
|
(92)
+12%
|
(82)
+10%
|
(74)
+10%
|
(58)
+22%
|
(49)
+15%
|
(42)
+15%
|
(37)
+13%
|
(35)
+4%
|
(40)
-15%
|
(42)
-5%
|
(41)
+4%
|
(34)
+16%
|
(30)
+13%
|
(27)
+10%
|
(21)
+21%
|
(17)
+20%
|
(11)
+32%
|
(6)
+46%
|
(4)
+31%
|
(3)
+21%
|
(3)
+18%
|
(1)
+51%
|
|